These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2907629)

  • 21. Cognitive disturbances in neuroleptic therapy.
    Strauss WH; Klieser E
    Acta Psychiatr Scand Suppl; 1990; 358():56-7. PubMed ID: 1978491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of clozapine-associated tardive dyskinesia.
    Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744
    [No Abstract]   [Full Text] [Related]  

  • 23. Nicotine-antipsychotic drug interactions and attentional performance in female rats.
    Rezvani AH; Levin ED
    Eur J Pharmacol; 2004 Feb; 486(2):175-82. PubMed ID: 14975706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative effectiveness of flupenthixol and risperidone on negative symptoms of schizophrenia].
    Philipp M; Lesch OM; Schmauss M; Dose M; Glaser T
    Psychiatr Prax; 2003 May; 30 Suppl 2():S94-6. PubMed ID: 14509050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Negative correlation between alpha-1-acid-glycoprotein plasma level and response to haloperidol in the acute treatment of schizophrenia.
    Levinson I; Levine S
    Biol Psychiatry; 1995 Aug; 38(3):198-200. PubMed ID: 7578667
    [No Abstract]   [Full Text] [Related]  

  • 26. [Drug treatment of schizophrenic psychoses in puerperium].
    Olbrich HM; Martin P
    Nervenarzt; 1994 Jul; 65(7):482-5. PubMed ID: 7800093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Long-term therapy of chronic schizophrenic patients with haloperidol decanoate].
    Roncoroni D
    Psychiatr Prax; 1984 Mar; 11(2):56-8. PubMed ID: 6144121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of haloperidol on the relationship of frontal lobe function to psychomotor poverty and disorganization syndromes.
    Allen DN; Anastasiou A; Goldstein G; Gilbertson M; van Kammen DP
    Psychiatry Res; 2000 Feb; 93(1):33-9. PubMed ID: 10699226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Switching to amisulpride due to hepatic complications.
    Yagdiran O; Haasen C; Nika E; Krausz M; Naber D
    Eur Psychiatry; 2002 May; 17(3):170-1. PubMed ID: 12052579
    [No Abstract]   [Full Text] [Related]  

  • 30. Rhabdomyolysis With Clozapine and Haloperidol Coadministration: A Case Report.
    Tseng CY; Chen MS; Lee KH; Ku CT; Chen YC; Lin PI
    J Clin Psychopharmacol; 2020; 40(5):502-504. PubMed ID: 32826485
    [No Abstract]   [Full Text] [Related]  

  • 31. Will the novel antipsychotics significantly ameliorate neuropsychological deficits and improve adaptive functioning in schizophrenia?
    Hawkins KA; Mohamed S; Woods SW
    Psychol Med; 1999 Jan; 29(1):1-8. PubMed ID: 10077288
    [No Abstract]   [Full Text] [Related]  

  • 32. Psychomotor impairment and cognitive disturbances induced by neuroleptics.
    King DJ
    Acta Psychiatr Scand Suppl; 1994; 380():53-8. PubMed ID: 7914050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic haloperidol treatment does not affect structure of attention in schizophrenia.
    Allen DN; Gilbertson MW; van Kammen DP; Kelley ME; Gurklis JA; Barry EJ
    Schizophr Res; 1997 May; 25(1):53-61. PubMed ID: 9176927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reply to: Implicit memory in schizophrenia: the problem that will not go away.
    Weickert TW
    Biol Psychiatry; 2012 Mar; 71(6):e17; discussion e19, e21. PubMed ID: 22074611
    [No Abstract]   [Full Text] [Related]  

  • 35. Disturbed circadian rest-activity cycles in schizophrenia patients: an effect of drugs?
    Wirz-Justice A; Haug HJ; Cajochen C
    Schizophr Bull; 2001; 27(3):497-502. PubMed ID: 11596850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between flupenthixol treatment and emergence of manic symptoms.
    Becker D; Grinberg Y; Weizman A; Mester R
    Eur Psychiatry; 2002 Oct; 17(6):349-52. PubMed ID: 12457745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antipsychotics and working memory in schizophrenia.
    Aleman A; de Haan EH
    Science; 2000 Jul; 289(5476):56-8. PubMed ID: 10928929
    [No Abstract]   [Full Text] [Related]  

  • 38. Clozapine effects on force control in schizophrenic patients.
    Vrtunski PB; Konicki PE; Jaskiw GE; Brescan DW; Kwon KY; Jurjus G
    Schizophr Res; 1998 Nov; 34(1-2):39-48. PubMed ID: 9824875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive deficits in adolescents with schizophrenia undergoing antipsychotic treatment.
    Chabrol H; Peresson G; Bonnet D
    Am J Psychiatry; 1999 Mar; 156(3):497-8. PubMed ID: 10080578
    [No Abstract]   [Full Text] [Related]  

  • 40. The influence of clozapine and typical neuroleptics on information processing of the central nervous system under clinical conditions in schizophrenic disorders: implications for fitness to drive.
    Grabe HJ; Wolf T; Grätz S; Laux G
    Neuropsychobiology; 1999 Nov; 40(4):196-201. PubMed ID: 10559702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.